Remove 2019 Remove Chronic Pain Remove Clinical Trials Remove Download
article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

NICE guideline [NG144] Published date: November 2019. Chronic pain. Chronic pain. Do not offer the following to manage chronic pain in adults: nabilone. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. 1 ] November 2019. [

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). No 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. 2019 ; Sarris et al. Conclusions.

article thumbnail

NORML 2019 Legislative Report

Cannabis Law Report

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.